British journal of pharmacology · 2025
A fibroblast-specific miRNA functional cluster in remote exosomes aggravates myocardial ischaemia/reperfusion injury via the Rap1b/ERK1/2 axis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Rui, Li Mingjue, Jin Jiarui, Fu Xiaokang, Zhu Hailin, Huang Xiaoxia, He Mingyuan, Li Zhihong, Lin Rongzhan, Lin Hairuo, Zhang Tong, Liao Wangjun, Bin Jianping, Wang Qiancheng, Zheng Cankun, Liao Yulin
Аннотация
BACKGROUND AND PURPOSE: Communication between various cardiac cells by paracrine factors and exosomes has an important role in myocardial ischaemia/reperfusion (I/R) injury. It remains unclear whether exosomes derived from healthy cardiac fibroblasts affect I/R injury and, if so, what are the underlying mechanisms?
EXPERIMENTAL APPROACH: Cardiac fibroblasts were isolated from neonatal rats, adult rats and adult rats subjected to I/R. Their exosomes were designated as follows: neonatal cardiac fibroblasts (N-Exo), adult rat cardiac fibroblasts (A-Exo) and cardiac fibroblasts in a remote non-ischaemic area (R-Exo). Apoptosis of cardiomyocytes and the role of a cluster of microRNAs from exosomes in I/R injury were investigated.
KEY RESULTS: N-Exo, A-Exo and R-Exo were taken up by ischaemic cardiomyocytes through clathrin heavy chain (Cltc)-mediated endocytosis, enhancing cardiomyocyte apoptosis and increasing myocardial infarct size in rats and mice. Inhibiting Cltc-mediated endocytosis with chlorpromazine reduced the pro-apoptotic effects of N-Exo in neonatal rat cardiomyocytes under anoxia/reoxygenation. A functional cluster of miRNAs (miR-9a-5p, miR-92b-3p, miR-181a-5p, miR-494-3p and miR-708-5p) from exosomes was identified and promoted cardiomyocyte apoptosis via a common gene, Rap1b. R-Exo downregulated cardiac Rap1b and Bcl2 in I/R rats. Mimics of these miRNAs reduced luciferase activity of the Rap1b gene and were blocked by site-directed mutagenesis of the Rap1b gene at miRNAs binding sites. Co-immunoprecipitation demonstrated that Rap1b protein bound to ERK1/2 and Cltc.
CONCLUSIONS AND IMPLICATIONS: Exosomes from non-ischaemic fibroblasts worsen I/R injury by promoting apoptosis of ischaemic cardiomyocytes through a cluster of miRNAs targeting the Rap1b/ERK1/2 pathway, highlighting Rap1b restoration as a potential therapeutic strategy.
EXPERIMENTAL APPROACH: Cardiac fibroblasts were isolated from neonatal rats, adult rats and adult rats subjected to I/R. Their exosomes were designated as follows: neonatal cardiac fibroblasts (N-Exo), adult rat cardiac fibroblasts (A-Exo) and cardiac fibroblasts in a remote non-ischaemic area (R-Exo). Apoptosis of cardiomyocytes and the role of a cluster of microRNAs from exosomes in I/R injury were investigated.
KEY RESULTS: N-Exo, A-Exo and R-Exo were taken up by ischaemic cardiomyocytes through clathrin heavy chain (Cltc)-mediated endocytosis, enhancing cardiomyocyte apoptosis and increasing myocardial infarct size in rats and mice. Inhibiting Cltc-mediated endocytosis with chlorpromazine reduced the pro-apoptotic effects of N-Exo in neonatal rat cardiomyocytes under anoxia/reoxygenation. A functional cluster of miRNAs (miR-9a-5p, miR-92b-3p, miR-181a-5p, miR-494-3p and miR-708-5p) from exosomes was identified and promoted cardiomyocyte apoptosis via a common gene, Rap1b. R-Exo downregulated cardiac Rap1b and Bcl2 in I/R rats. Mimics of these miRNAs reduced luciferase activity of the Rap1b gene and were blocked by site-directed mutagenesis of the Rap1b gene at miRNAs binding sites. Co-immunoprecipitation demonstrated that Rap1b protein bound to ERK1/2 and Cltc.
CONCLUSIONS AND IMPLICATIONS: Exosomes from non-ischaemic fibroblasts worsen I/R injury by promoting apoptosis of ischaemic cardiomyocytes through a cluster of miRNAs targeting the Rap1b/ERK1/2 pathway, highlighting Rap1b restoration as a potential therapeutic strategy.